| 1 |
Penack O, Marchetti M, Aljurf M, et al. Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation[J]. Lancet Haematol, 2024, 11(2): e147-e159.
|
| 2 |
胡楠，智发朝. 胃肠道移植物抗宿主病的研究进展[J]. 现代消化及介入诊疗，2025, 30(12): 1229-1233.
|
| 3 |
李明月． 造血干细胞移植患者感染病原菌的分布、耐药性及影响因素分析[D]. 广州：南方医科大学，2023.
|
| 4 |
岑锡侃，戴泽，周玉平. 造血干细胞移植相关的移植物抗宿主病肠道菌群失调机制及治疗分析[J]. 浙江临床医学，2024, 26(2): 290-292.
|
| 5 |
Gao F, Wu H, Wang L, et al. Altered intestinal microbiome and epithelial damage aggravate intestinal graft-versus-host disease[J]. Gut Microbes, 2023, 15(1)：2221821.
|
| 6 |
中国抗癌协会肿瘤与微生态专业委员会. 肠道微生态与造血干细胞移植相关性中国专家共识[J]. 国际肿瘤学杂志，2021, 48(3): 129-135.
|
| 7 |
Koyama M, Hippe DS, Srinivasan S, et al. Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity[J]. Immunity, 2023, 56(8): 1876-1893.
|
| 8 |
Kao PHN, Kline KA. Dr. Jekyll and Mr. Hide: How enterococcus faecalis Subverts the Host Immune Response to Cause Infection[J]. J Mol Biol, 2019, 431(16)：2932-2945.
|
| 9 |
Hayase E, Hayase T, Jamal MA, et al. Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease[J]. Cell, 2022, 185(20): 3705-3719.
|
| 10 |
Panahi P, Hashemian AH, Payandeh M, et al. Gut microbiota and graft-versus-host disease in hematopoietic stem cell transplant patients[J]. Iran J Microbiol, 2024, 16(5)：648-654.
|
| 11 |
Gavriilaki E, Christoforidi M, Ouranos K, et al. Alteration of gut microbiota composition and diversity in acute and/or chronic graft-versus-host disease following hematopoietic stem cell transplantation: a prospective cohort study[J]. Int J Mol Sci, 2024, 25(11)：5789.
|
| 12 |
中华医学会血液学分会干细胞应用学组. 异基因造血干细胞移植急性移植物抗宿主病诊断与治疗中国专家共识(2024年版)[J]. 中华血液学杂志，2024, 45(6): 525-533.
|
| 13 |
Luo C, Huang X, Wei L, et al. Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials[J]. Front Immunol, 2023, 14：1211171.
|
| 14 |
柳安雄，王伟，钟自彪，等. 间充质干细胞免疫调节作用在终末期肝病治疗中的研究进展[J/OL]. 中华移植杂志：电子版，2020, 14(1): 49-53.
|
| 15 |
Jiang E, Qian K, Wang L, et al. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease: a multicentre, randomized, double-blind, phase 2 trial[J]. BMC Med, 2024, 22(1): 555.
|
| 16 |
Yazdandoust E, Hajifathali A, Roshandel E, et al. Gut microbiota intervention by pre and probiotics can induce regulatory T cells and reduce the risk of severe acute GVHD following allogeneic hematopoietic stem cell transplantation[J]. Transpl Immunol, 2023, 78：101836.
|
| 17 |
Biliński J, Jasiński M, Basak GW. The role of fecal microbiota transplantation in the treatment of acute graft-versus-host disease[J]. Biomedicines, 2022, 10(4): 837.
|
| 18 |
温燕玲，杨静雯，王鲁星，等. 造血干细胞移植并发胃肠道急性移植物抗宿主病患者营养管理的最佳证据总结[J]. 中华护理教育，2025, 22(4): 494-501.
|
| 19 |
单淑慧，胡静，刘佳，等. 成人造血干细胞移植患者饮食管理最佳证据总结[J]. 护理学报，2024, 31(16): 67-73.
|
| 20 |
Barban JB, Simões BP, de Carvalho Moraes BDG, et al. Brazilian nutritional consensus in hematopoietic stem cell transplantation: adults[J]. Einstein (São Paulo), 2020, 18：AE4530
|
| 21 |
Margolis KG, Cryan JF, Mayer EA. The microbiota-gut-brain axis: from motility to mood[J]. Gastroenterology, 2021, 160(5): 1486-1501.
|